Showing 3,621 - 3,640 results of 6,719 for search '"Diabetes"', query time: 0.08s Refine Results
  1. 3621
  2. 3622
  3. 3623
  4. 3624
  5. 3625

    Long term cost-effectiveness analysis of IDegLira in the treatment of type 2 diabetes patients compared to GLP-1RA added to basal insulin after IDegLira entered the national reimbursement drug list in China. by Dunming Xiao, Junling Weng, Lei Zhang, Chang Xing, Yan Wei, Yingyao Chen

    Published 2025-01-01
    “…This study aimed to evaluate the long-term cost-effectiveness of IDegLira versus GLP-1RA added to basal insulin regimen (combined regimen) for patients with type 2 diabetes in China.<h4>Methods</h4>Based on the perspective of the health system, the study adopts the Swedish Institute for Health Economics diabetes cohort model. …”
    Get full text
    Article
  6. 3626
  7. 3627

    Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies by Rohan Khera, Yuan Lu, Harlan M Krumholz, Martijn J Schuemie, Ruijun Chen, George Hripcsak, Marc A Suchard, Patrick B Ryan, Anna Ostropolets

    Published 2022-06-01
    “…Introduction Therapeutic options for type 2 diabetes mellitus (T2DM) have expanded over the last decade with the emergence of cardioprotective novel agents, but without such data for older drugs, leaving a critical gap in our understanding of the relative effects of T2DM agents on cardiovascular risk.Methods and analysis The large-scale evidence generations across a network of databases for T2DM (LEGEND-T2DM) initiative is a series of systematic, large-scale, multinational, real-world comparative cardiovascular effectiveness and safety studies of all four major second-line anti-hyperglycaemic agents, including sodium–glucose co-transporter-2 inhibitor, glucagon-like peptide-1 receptor agonist, dipeptidyl peptidase-4 inhibitor and sulfonylureas. …”
    Get full text
    Article
  8. 3628
  9. 3629
  10. 3630
  11. 3631
  12. 3632
  13. 3633
  14. 3634
  15. 3635

    Comparing the Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists with Sodium-Glucose Cotransporter 2 Inhibitors for Obese Type 2 Diabetes Patients Uncontrolled on Metformin: A Systematic Review and Meta-Analysis of Randomized Clinical Trials by Lu Ding, Bang Sun, Xinhua Xiao

    Published 2020-01-01
    “…To conduct the first meta-analysis of randomized controlled trials (RCTs) comparing glucagon-like peptide 1 receptor agonists (GLP-1RAs) with sodium-glucose cotransporter 2 inhibitors (SGLT-2is) for obese type 2 diabetes (T2D) patients uncontrolled on metformin. …”
    Get full text
    Article
  16. 3636
  17. 3637
  18. 3638

    Magnitude of fruit and vegetable consumption and its associated factors among patients with type 2 diabetes mellitus (T2DM) attending health services at selected health centers in Yeka subcity, Addis Ababa: a cross-sectional study by Lelisa Worku, Burtukan Hussien, Teshome Bekele Elema, Taferi Atomsa Rekiti, Amana Ogatu Luke, Addisu Tadesse Sime

    Published 2024-07-01
    “…Objective To assess the fruit and vegetable (FV) consumption, and associated factors among patients with type 2 diabetes mellitus (T2DM) attending health services at selected health centres.Methods Institution-based cross-sectional study design was conducted. …”
    Get full text
    Article
  19. 3639
  20. 3640